Polar Asset Management Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-10,000
| Closed | -$409K | – | 882 |
|
2024
Q2 | $409K | Sell |
10,000
-15,000
| -60% | -$613K | 0.01% | 413 |
|
2024
Q1 | $1.06M | Sell |
25,000
-15,000
| -38% | -$634K | 0.02% | 416 |
|
2023
Q4 | $1.7M | Sell |
40,000
-7,400
| -16% | -$314K | 0.03% | 355 |
|
2023
Q3 | $1.03M | Buy |
+47,400
| New | +$1.03M | 0.02% | 439 |
|